Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1998 Jul;78(1):50–55. doi: 10.1038/bjc.1998.441

Cell cycle phase influences tumour cell sensitivity to aminolaevulinic acid-induced photodynamic therapy in vitro.

L Wyld 1, O Smith 1, J Lawry 1, M W Reed 1, N J Brown 1
PMCID: PMC2062939  PMID: 9662250

Abstract

Photodynamic therapy (PDT) is a form of cancer treatment based on the destruction of cells by the interaction of light, oxygen and a photosensitizer. Aminolaevulinic acid (ALA) is the prodrug of the photosensitizer protoporphyrin IX (PpIX). ALA-induced PDT depends on the rate of cellular synthesis of PpIX, which may vary with cell cycle phase. This study has investigated the relationship between cell cycle phase, PpIX generation and phototoxicity in synchronized and unsynchronized bladder cancer cells (HT1197). In unsynchronized cells, relative PpIX fluorescence values (arbitrary units) were significantly different between cell cycle phases after a 1-h ALA incubation (G1 24.8 +/- 0.7; S-phase, 32.7 +/- 0.8, P < 0.05; G2 35.4 +/- 0.8, P < 0.05). In synchronized cells after a 1-h ALA incubation, cells in G1 produced less PpIX than those in S-phase or G2 [6.65 +/- 1.1 ng per 10(5) cells compared with 15.5 +/- 2.1 (P < 0.05), and 8.1 +/- 1.8 ng per 10(5) cells (not significant) respectively] and were significantly less sensitive to ALA-induced PDT (% survival, G1 76.2 +/- 8.3; S-phase 49.7 +/- 4.6, P < 0.05; G2 44.2 +/- 2.4, P < 0.05). This differential response in tumour cells may have implications for clinical PDT, resulting in treatment resistance and possible failure in complete tumour response.

Full text

PDF
50

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERLIN N. I., NEUBERGER A., SCOTT J. J. The metabolism of delta -aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N. Biochem J. 1956 Sep;64(1):80–90. doi: 10.1042/bj0640080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brown N. C., Eliasson R., Reichard P., Thelander L. Spectrum and iron content of protein B2 from ribonucleoside diphosphate reductase. Eur J Biochem. 1969 Jul;9(4):512–518. doi: 10.1111/j.1432-1033.1969.tb00639.x. [DOI] [PubMed] [Google Scholar]
  3. Christensen T., Feren K., Moan J., Pettersen E. Photodynamic effects of haematoporphyrin derivative on synchronized and asynchronous cells of different origin. Br J Cancer. 1981 Nov;44(5):717–724. doi: 10.1038/bjc.1981.258. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Churchill J. R., Studzinski G. P. Thymidine as synchronizing agent. 3. Persistence of cell cycle patterns of phosphatase activities and elevation of nuclease activity during inhibition of DNA synthesis. J Cell Physiol. 1970 Jun;75(3):297–303. doi: 10.1002/jcp.1040750306. [DOI] [PubMed] [Google Scholar]
  5. D'Hallewin M. A., Baert L. Long-term results of whole bladder wall photodynamic therapy for carcinoma in situ of the bladder. Urology. 1995 May;45(5):763–767. doi: 10.1016/S0090-4295(99)80080-6. [DOI] [PubMed] [Google Scholar]
  6. Dolbeare F., Selden J. R. Immunochemical quantitation of bromodeoxyuridine: application to cell-cycle kinetics. Methods Cell Biol. 1994;41:297–316. [PubMed] [Google Scholar]
  7. Dougherty T. J., Kaufman J. E., Goldfarb A., Weishaupt K. R., Boyle D., Mittleman A. Photoradiation therapy for the treatment of malignant tumors. Cancer Res. 1978 Aug;38(8):2628–2635. [PubMed] [Google Scholar]
  8. FALK J. E., PORRA R. J., BROWN A., MOSS F., LARMINIE H. E. Effect of oxygen tension on haem and porphyrin biosynthesis. Nature. 1959 Oct 17;184:1217–1219. doi: 10.1038/1841217a0. [DOI] [PubMed] [Google Scholar]
  9. Fukuda H., Batlle A. M., Riley P. A. Kinetics of porphyrin accumulation in cultured epithelial cells exposed to ALA. Int J Biochem. 1993 Oct;25(10):1407–1410. doi: 10.1016/0020-711x(93)90689-c. [DOI] [PubMed] [Google Scholar]
  10. HEWITT H. B., WILSON C. W. The effect of tissue oxygen tension on the radiosensitivity of leukaemia cells irradiated in situ in the livers of leukaemic mice. Br J Cancer. 1959 Dec;13:675–684. doi: 10.1038/bjc.1959.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Humphrey R. M., Dewey W. C. Radiosensitivity of normal and 5-bromodeoxyuridine treated mammalian cells during different phases of the cell cycle. Exp Cell Res. 1965 Sep;39(2):483–495. doi: 10.1016/0014-4827(65)90052-2. [DOI] [PubMed] [Google Scholar]
  12. Kaczmarek L. Protooncogene expression during the cell cycle. Lab Invest. 1986 Apr;54(4):365–376. [PubMed] [Google Scholar]
  13. Kriegmair M., Baumgartner R., Lumper W., Waidelich R., Hofstetter A. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. Br J Urol. 1996 May;77(5):667–671. doi: 10.1046/j.1464-410x.1996.09717.x. [DOI] [PubMed] [Google Scholar]
  14. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  15. Ma L. W., Moan J., Steen H. B., Iani V. Anti-tumour activity of photodynamic therapy in combination with mitomycin C in nude mice with human colon adenocarcinoma. Br J Cancer. 1995 May;71(5):950–956. doi: 10.1038/bjc.1995.184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Moan J., McGhie J., Jacobsen P. B. Photodynamic effects on cells in vitro exposed to hematoporphyrin derivative and light. Photochem Photobiol. 1983 Jun;37(6):599–604. doi: 10.1111/j.1751-1097.1983.tb04527.x. [DOI] [PubMed] [Google Scholar]
  17. Moan J., Sommer S. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. Cancer Res. 1985 Apr;45(4):1608–1610. [PubMed] [Google Scholar]
  18. Neckers L. M., Cossman J. Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3494–3498. doi: 10.1073/pnas.80.11.3494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Nocka K. H., Pelus L. M. Cell cycle specific effects of deferoxamine on human and murine hematopoietic progenitor cells. Cancer Res. 1988 Jul 1;48(13):3571–3575. [PubMed] [Google Scholar]
  20. Rasheed S., Gardner M. B., Rongey R. W., Nelson-Rees W. A., Arnstein P. Human bladder carcinoma: characterization of two new tumor cell lines and search for tumor viruses. J Natl Cancer Inst. 1977 Apr;58(4):881–890. doi: 10.1093/jnci/58.4.881. [DOI] [PubMed] [Google Scholar]
  21. Reed M. W., Mullins A. P., Anderson G. L., Miller F. N., Wieman T. J. The effect of photodynamic therapy on tumor oxygenation. Surgery. 1989 Jul;106(1):94–99. [PubMed] [Google Scholar]
  22. Rittenhouse-Diakun K., Van Leengoed H., Morgan J., Hryhorenko E., Paszkiewicz G., Whitaker J. E., Oseroff A. R. The role of transferrin receptor (CD71) in photodynamic therapy of activated and malignant lymphocytes using the heme precursor delta-aminolevulinic acid (ALA). Photochem Photobiol. 1995 May;61(5):523–528. doi: 10.1111/j.1751-1097.1995.tb02356.x. [DOI] [PubMed] [Google Scholar]
  23. Schick E., Kaufmann R., Rück A., Hainzl A., Boehncke W. H. Influence of activation and differentiation of cells on the effectiveness of photodynamic therapy. Acta Derm Venereol. 1995 Jul;75(4):276–279. doi: 10.2340/0001555575276279. [DOI] [PubMed] [Google Scholar]
  24. Schneckenburger H., Rück A., Bartos B., Steiner R. Intracellular distribution of photosensitizing porphyrins measured by video-enhanced fluorescence microscopy. J Photochem Photobiol B. 1988 Nov;2(3):355–363. doi: 10.1016/1011-1344(88)85054-1. [DOI] [PubMed] [Google Scholar]
  25. Sibille A., Lambert R., Souquet J. C., Sabben G., Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology. 1995 Feb;108(2):337–344. doi: 10.1016/0016-5085(95)90058-6. [DOI] [PubMed] [Google Scholar]
  26. Sinclair W. K., Morton R. A. X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells. Radiat Res. 1966 Nov;29(3):450–474. [PubMed] [Google Scholar]
  27. Stein G. S., Borun T. W. The synthesis of acidic chromosomal proteins during the cell cycle of HeLa S-3 cells. I. The accelerated accumulation of acidic residual nuclear protein before the initiation of DNA replication. J Cell Biol. 1972 Feb;52(2):292–307. doi: 10.1083/jcb.52.2.292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Stratford I. J., Stephens M. A. The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay. Int J Radiat Oncol Biol Phys. 1989 Apr;16(4):973–976. doi: 10.1016/0360-3016(89)90898-5. [DOI] [PubMed] [Google Scholar]
  29. TERASIMA T., TOLMACH L. J. Variations in several responses of HeLa cells to x-irradiation during the division cycle. Biophys J. 1963 Jan;3:11–33. doi: 10.1016/s0006-3495(63)86801-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Weishaupt K. R., Gomer C. J., Dougherty T. J. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. Cancer Res. 1976 Jul;36(7 Pt 1):2326–2329. [PubMed] [Google Scholar]
  31. Wyld L., Burn J. L., Reed M. W., Brown N. J. Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX. Br J Cancer. 1997;76(6):705–712. doi: 10.1038/bjc.1997.450. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES